$8.11
0.354.56%
Pre-Market: 6:33 PM EDT
15 minutes delayed
89bio
ETNBNASDAQ
89bio (NASDAQ:ETNB) Stock, Analyst Ratings, Price Targets, Predictions
89bio Inc has a consensus price target of $26.82, established from looking at the 64 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, Cantor Fitzgerald, and Cantor Fitzgerald on July 1, 2024, June 17, 2024, and June 12, 2024. With an average price target of $29 between Cantor Fitzgerald, Cantor Fitzgerald, and Cantor Fitzgerald, there's an implied 257.42% upside for 89bio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
HC Wainwright & Co.
Evercore ISI Group
B of A Securities
Oppenheimer
1calculated from analyst ratings
Analyst Ratings for 89bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/01/2024 | Buy Now | 257.42% | Cantor Fitzgerald | Kristen Kluska | $29 → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | Buy Now | 257.42% | Cantor Fitzgerald | Kristen Kluska | $29 → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 06/12/2024 | Buy Now | 257.42% | Cantor Fitzgerald | Kristen Kluska | $29 → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 06/11/2024 | Buy Now | 257.42% | HC Wainwright & Co. | Ed Arce | $29 → $29 | Reiterates | Buy → Buy | Get Alert |
| 05/17/2024 | Buy Now | 257.42% | Cantor Fitzgerald | Kristen Kluska | → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 05/17/2024 | Buy Now | 257.42% | HC Wainwright & Co. | Ed Arce | → $29 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2024 | Buy Now | 257.42% | HC Wainwright & Co. | Ed Arce | → $29 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | Buy Now | 306.72% | Evercore ISI Group | Liisa Bayko | $37 → $33 | Maintains | Outperform | Get Alert |
| 05/10/2024 | Buy Now | 257.42% | HC Wainwright & Co. | Ed Arce | $31 → $29 | Maintains | Buy | Get Alert |
| 04/22/2024 | Buy Now | 269.74% | B of A Securities | Alexandria Hammond | → $30 | Assumes | → Buy | Get Alert |
| 04/05/2024 | Buy Now | 257.42% | Cantor Fitzgerald | Kristen Kluska | → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 03/27/2024 | Buy Now | 282.07% | HC Wainwright & Co. | Ed Arce | $31 → $31 | Maintains | Buy | Get Alert |
| 03/13/2024 | Buy Now | 282.07% | HC Wainwright & Co. | Ed Arce | $31 → $31 | Maintains | Buy | Get Alert |
| 03/07/2024 | Buy Now | 356.02% | Evercore ISI Group | Liisa Bayko | $29 → $37 | Maintains | Outperform | Get Alert |
| 03/06/2024 | Buy Now | 356.02% | Evercore ISI Group | Liisa Bayko | $29 → $37 | Maintains | Outperform | Get Alert |
| 03/05/2024 | Buy Now | — | Oppenheimer | Jay Olson | — | Maintains | Perform | Get Alert |
| 03/04/2024 | Buy Now | 257.42% | Cantor Fitzgerald | Kristen Kluska | → $29 | Reiterates | Overweight → Overweight | Get Alert |
| 03/01/2024 | Buy Now | 72.55% | RBC Capital | Brian Abrahams | $15 → $14 | Maintains | Sector Perform | Get Alert |
| 03/01/2024 | Buy Now | 282.07% | HC Wainwright & Co. | Ed Arce | $32 → $31 | Maintains | Buy | Get Alert |
| 01/12/2024 | Buy Now | 84.87% | RBC Capital | Brian Abrahams | → $15 | Downgrade | Outperform → Sector Perform | Get Alert |
| 12/20/2023 | Buy Now | 294.39% | HC Wainwright & Co. | Ed Arce | $35 → $32 | Maintains | Buy | Get Alert |
| 12/05/2023 | Buy Now | 331.37% | HC Wainwright & Co. | Ed Arce | → $35 | Reiterates | Buy → Buy | Get Alert |
| 11/28/2023 | Buy Now | 331.37% | HC Wainwright & Co. | Ed Arce | → $35 | Reiterates | Buy → Buy | Get Alert |
| 11/09/2023 | Buy Now | 195.8% | RBC Capital | Brian Abrahams | $27 → $24 | Maintains | Outperform | Get Alert |
| 10/12/2023 | Buy Now | 208.12% | UBS | Eliana Merle | $36 → $25 | Maintains | Buy | Get Alert |
| 10/11/2023 | Buy Now | 232.77% | RBC Capital | Brian Abrahams | $34 → $27 | Maintains | Outperform | Get Alert |
| 09/22/2023 | Buy Now | 319.04% | RBC Capital | Brian Abrahams | → $34 | Reiterates | Outperform → Outperform | Get Alert |
| 08/28/2023 | Buy Now | 343.69% | UBS | Eliana Merle | → $36 | Initiates | → Buy | Get Alert |
| 08/10/2023 | Buy Now | 331.37% | HC Wainwright & Co. | Ed Arce | → $35 | Reiterates | Buy → Buy | Get Alert |
| 08/10/2023 | Buy Now | 380.67% | Cantor Fitzgerald | Kristen Kluska | $41 → $39 | Maintains | Overweight | Get Alert |
| 08/10/2023 | Buy Now | 319.04% | RBC Capital | Brian Abrahams | $33 → $34 | Maintains | Outperform | Get Alert |
| 07/03/2023 | Buy Now | 356.02% | BTIG | Justin Zelin | $30 → $37 | Maintains | Buy | Get Alert |
| 06/13/2023 | Buy Now | 503.92% | Evercore ISI Group | Liisa Bayko | → $49 | Initiates | → Outperform | Get Alert |
| 05/11/2023 | Buy Now | 269.74% | Oppenheimer | Jay Olson | → $30 | Reiterates | Outperform → Outperform | Get Alert |
| 05/08/2023 | Buy Now | 331.37% | HC Wainwright & Co. | Ed Arce | $30 → $35 | Maintains | Buy | Get Alert |
| 05/05/2023 | Buy Now | 405.32% | Cantor Fitzgerald | Kristen Kluska | $40 → $41 | Maintains | Overweight | Get Alert |
| 05/05/2023 | Buy Now | 306.72% | RBC Capital | Brian Abrahams | $36 → $33 | Maintains | Outperform | Get Alert |
| 03/23/2023 | Buy Now | 516.24% | Raymond James | Steven Seedhouse | $25 → $50 | Maintains | Strong Buy | Get Alert |
| 03/23/2023 | Buy Now | 269.74% | HC Wainwright & Co. | Ed Arce | $25 → $30 | Maintains | Buy | Get Alert |
| 03/22/2023 | Buy Now | 343.69% | RBC Capital | Brian Abrahams | $27 → $36 | Maintains | Outperform | Get Alert |
| 03/22/2023 | Buy Now | 516.24% | Raymond James | Steven Seedhouse | $25 → $50 | Maintains | Strong Buy | Get Alert |
| 03/22/2023 | Buy Now | 454.62% | Cantor Fitzgerald | Kristen Kluska | $34 → $45 | Maintains | Overweight | Get Alert |
| 03/20/2023 | Buy Now | 208.12% | HC Wainwright & Co. | Ed Arce | $27 → $25 | Maintains | Buy | Get Alert |
| 03/14/2023 | Buy Now | 232.77% | RBC Capital | Brian Abrahams | → $27 | Reiterates | → Outperform | Get Alert |
| 03/06/2023 | Buy Now | 319.04% | Cantor Fitzgerald | Kristen Kluska | → $34 | Reiterates | → Overweight | Get Alert |
| 02/21/2023 | Buy Now | 121.85% | Oppenheimer | Jay Olson | $12 → $18 | Maintains | Outperform | Get Alert |
| 02/07/2023 | Buy Now | 232.77% | HC Wainwright & Co. | Ed Arce | → $27 | Reiterates | → Buy | Get Alert |
| 11/11/2022 | Buy Now | 257.42% | RBC Capital | Brian Abrahams | $35 → $29 | Maintains | Outperform | Get Alert |
| 09/14/2022 | Buy Now | 208.12% | Raymond James | Steven Seedhouse | $14 → $25 | Maintains | Strong Buy | Get Alert |
| 08/17/2022 | Buy Now | 232.77% | HC Wainwright & Co. | Ed Arce | $26 → $27 | Maintains | Buy | Get Alert |
| 07/28/2022 | Buy Now | 220.45% | HC Wainwright & Co. | Ed Arce | $29 → $26 | Maintains | Buy | Get Alert |
| 07/11/2022 | Buy Now | 257.42% | SVB Leerink | Thomas Smith | $50 → $29 | Maintains | Outperform | Get Alert |
| 06/30/2022 | Buy Now | 84.87% | Oppenheimer | Jay Olson | $40 → $15 | Maintains | Outperform | Get Alert |
| 06/30/2022 | Buy Now | 72.55% | Raymond James | Steven Seedhouse | $12 → $14 | Maintains | Strong Buy | Get Alert |
| 06/29/2022 | Buy Now | 195.8% | BTIG | Justin Zelin | $28 → $24 | Maintains | Buy | Get Alert |
| 05/18/2022 | Buy Now | 134.17% | Piper Sandler | Yasmeen Rahimi | $54 → $19 | Maintains | Overweight | Get Alert |
| 05/13/2022 | Buy Now | 392.99% | Oppenheimer | Jay Olson | $49 → $40 | Maintains | Outperform | Get Alert |
| 05/12/2022 | Buy Now | 294.39% | RBC Capital | Brian Abrahams | $35 → $32 | Maintains | Outperform | Get Alert |
| 05/12/2022 | Buy Now | 47.9% | Raymond James | Steven Seedhouse | $33 → $12 | Upgrade | Outperform → Strong Buy | Get Alert |
| 03/25/2022 | Buy Now | 516.24% | SVB Leerink | Thomas Smith | $62 → $50 | Maintains | Outperform | Get Alert |
| 12/20/2021 | Buy Now | 466.94% | HC Wainwright & Co. | Ed Arce | — | Initiates | → Buy | Get Alert |
| 10/26/2021 | Buy Now | 503.92% | Cantor Fitzgerald | Kristen Kluska | — | Assumes | → Overweight | Get Alert |
| 08/13/2021 | Buy Now | 466.94% | RBC Capital | Brian Abrahams | — | Maintains | Outperform | Get Alert |
| 08/13/2021 | Buy Now | 306.72% | Raymond James | Steven Seedhouse | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for 89bio (ETNB) stock?
The latest price target for 89bio (NASDAQ:ETNB) was reported by Cantor Fitzgerald on July 1, 2024. The analyst firm set a price target for $29.00 expecting ETNB to rise to within 12 months (a possible 257.42% upside). 32 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for 89bio (ETNB)?
The latest analyst rating for 89bio (NASDAQ:ETNB) was provided by Cantor Fitzgerald, and 89bio reiterated their overweight rating.
When was the last upgrade for 89bio (ETNB)?
The last upgrade for 89bio Inc happened on May 12, 2022 when Raymond James raised their price target to $12. Raymond James previously had an outperform for 89bio Inc.
When was the last downgrade for 89bio (ETNB)?
The last downgrade for 89bio Inc happened on January 12, 2024 when RBC Capital changed their price target from N/A to $15 for 89bio Inc.
When is the next analyst rating going to be posted or updated for 89bio (ETNB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of 89bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for 89bio was filed on July 1, 2024 so you should expect the next rating to be made available sometime around July 1, 2025.
Is the Analyst Rating 89bio (ETNB) correct?
While ratings are subjective and will change, the latest 89bio (ETNB) rating was a reiterated with a price target of $29.00 to $29.00. The current price 89bio (ETNB) is trading at is $8.11, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.